FDA.reportPublic FDA data

caffeine / ergotamine / ibuprofen

RxCUI
1009128
RxNorm name
caffeine / ergotamine / ibuprofen
Term type
MIN
Status
Active
Updated
2026-10-29 06:00:25

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
caffeine1886
ergotamine4025
ibuprofen5640

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRcaffeine / ergotamine / ibuprofen1NAMES
RxNorm Namecaffeine / ergotamine / ibuprofen1NAMES
TTYMIN1ATTRIBUTES
RxCUI10091281CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCM02AAAntiinflammatory preparations, non-steroids for topical useATC1-4ibuprofen
ATCG02CCAntiinflammatory products for vaginal administrationATC1-4ibuprofen
ATCN02CAErgot alkaloidsATC1-4ergotamine
ATCC01EBOther cardiac preparationsATC1-4ibuprofen
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCR02AXOther throat preparationsATC1-4ibuprofen
ATCM01AEPropionic acid derivativesATC1-4ibuprofen
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD004879ErgotaminesCHEMhas_chemical_structureergotamine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175766Ergotamine DerivativeEPChas_epcergotamine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175722Nonsteroidal Anti-inflammatory DrugEPChas_epcibuprofen
FDASPLN0000000160Cyclooxygenase InhibitorsMOAhas_moaibuprofen
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD001393AzolesCHEMci_chemclassergotamine
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD004878ErgotamineCHEMhas_ingredientergotamine
MEDRTD007052IbuprofenCHEMhas_ingredientibuprofen
MEDRTD018942MacrolidesCHEMci_chemclassergotamine
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001171Arthritis, JuvenileDISEASEmay_treatibuprofen
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treatibuprofen
MEDRTD001249AsthmaDISEASEci_withibuprofen
MEDRTD016535Bronchial HyperreactivityDISEASEci_withibuprofen
MEDRTD002062BursitisDISEASEmay_treatibuprofen
MEDRTD003027Cluster HeadacheDISEASEmay_treatergotamine
MEDRTD003327Coronary DiseaseDISEASEci_withergotamine
MEDRTD004342Drug HypersensitivityDISEASEci_withergotamine
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withibuprofen
MEDRTD004412DysmenorrheaDISEASEmay_treatibuprofen
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_treatibuprofen
MEDRTD006073GoutDISEASEmay_treatibuprofen
MEDRTD006973HypertensionDISEASEci_withergotamine
MEDRTD007249InflammationDISEASEmay_treatibuprofen
MEDRTD007674Kidney DiseasesDISEASEci_withergotamine
MEDRTD008107Liver DiseasesDISEASEci_withergotamine
MEDRTD008595MenorrhagiaDISEASEmay_treatibuprofen
MEDRTD008881Migraine DisordersDISEASEmay_treatergotamine
MEDRTD010003OsteoarthritisDISEASEmay_treatibuprofen
MEDRTD010146PainDISEASEmay_preventibuprofen
MEDRTD016491Peripheral Vascular DiseasesDISEASEci_withergotamine
MEDRTD010149Postoperative PainDISEASEmay_treatibuprofen
MEDRTD011247PregnancyDISEASEci_withergotamine
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withibuprofen
MEDRTD011269Pregnancy, AbdominalDISEASEci_withibuprofen
MEDRTD011293Premenstrual SyndromeDISEASEmay_treatibuprofen
MEDRTD012220RhinitisDISEASEci_withibuprofen
MEDRTD018805SepsisDISEASEci_withergotamine
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatibuprofen
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaergotamine
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moaibuprofen
MEDRTN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaergotamine
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAci_moaergotamine
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moaergotamine
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaergotamine
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_peergotamine
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008831Decreased Platelet Activating Factor ProductionPEhas_peibuprofen
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peibuprofen
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_peibuprofen
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000009705Increased Uterine Smooth Muscle Contraction or TonePEhas_peergotamine
MEDRTN0000000026Hepatic MetabolismPKhas_pkibuprofen
MEDRTN0000000042Renal ExcretionPKhas_pkibuprofen

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI